Recent advances in emission computed tomography

Research output: Contribution to journalArticle

Abstract

Recent advances in emission computed tomography include those in position emission tomography (PET) and single-photon emission computed tomography (SPECT). Despite its high instrumentation costs, PET is unique among other modalities in its ability for metabolic and physiological imaging. After more than two decades of intensive instrumentation development and application, PET is entering a new era with an increased number of commercial systems and hospital-based cyclotrons being installed in clinical departments. Future research is directed towards high resolution PET imaging systems, pharmaceutical development and exploration of new areas of clinical applications. Due to lower instrumentation costs, SPECT systems are much more widely available than PET. On the other hand, SPECT's limitations include lower sensitivity, difficulties in attenuation and scatter compensation, and availability of truly metabolic and physiological agents. However, in the last few years we have witnessed tremendous advances made in SPECT imaging. In particular, SPECT systems with multiple detectors are now commercially available, offering much better sensitivity and spatial resolution compared to older generation systems and the potential of simultaneous transmission-emission computed tomography. Image processing and reconstruction methods are being developed to provide better image quality and quantitative accuracy. New SPECT radiopharmaceuticals for metabolic and physiological studies are under investigation. These advances will provide an alternative to metabolic and physiological imaging at much lower costs. The paper highlights recent advances in both PET and SPECT and their effects on the future of medical imaging.

Original languageEnglish (US)
Pages (from-to)608-609
Number of pages2
JournalAnnals of Biomedical Engineering
Volume19
Issue number5
StatePublished - 1991
Externally publishedYes

Fingerprint

Single photon emission computed tomography
Tomography
Imaging techniques
Costs
Medical imaging
Cyclotrons
Image reconstruction
Imaging systems
Drug products
Image quality
Image processing
Availability
Detectors

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Recent advances in emission computed tomography. / Tsui, Benjamin.

In: Annals of Biomedical Engineering, Vol. 19, No. 5, 1991, p. 608-609.

Research output: Contribution to journalArticle

@article{94887b2d42ad4f2cbb1c058b61644411,
title = "Recent advances in emission computed tomography",
abstract = "Recent advances in emission computed tomography include those in position emission tomography (PET) and single-photon emission computed tomography (SPECT). Despite its high instrumentation costs, PET is unique among other modalities in its ability for metabolic and physiological imaging. After more than two decades of intensive instrumentation development and application, PET is entering a new era with an increased number of commercial systems and hospital-based cyclotrons being installed in clinical departments. Future research is directed towards high resolution PET imaging systems, pharmaceutical development and exploration of new areas of clinical applications. Due to lower instrumentation costs, SPECT systems are much more widely available than PET. On the other hand, SPECT's limitations include lower sensitivity, difficulties in attenuation and scatter compensation, and availability of truly metabolic and physiological agents. However, in the last few years we have witnessed tremendous advances made in SPECT imaging. In particular, SPECT systems with multiple detectors are now commercially available, offering much better sensitivity and spatial resolution compared to older generation systems and the potential of simultaneous transmission-emission computed tomography. Image processing and reconstruction methods are being developed to provide better image quality and quantitative accuracy. New SPECT radiopharmaceuticals for metabolic and physiological studies are under investigation. These advances will provide an alternative to metabolic and physiological imaging at much lower costs. The paper highlights recent advances in both PET and SPECT and their effects on the future of medical imaging.",
author = "Benjamin Tsui",
year = "1991",
language = "English (US)",
volume = "19",
pages = "608--609",
journal = "Annals of Biomedical Engineering",
issn = "0090-6964",
publisher = "Springer Netherlands",
number = "5",

}

TY - JOUR

T1 - Recent advances in emission computed tomography

AU - Tsui, Benjamin

PY - 1991

Y1 - 1991

N2 - Recent advances in emission computed tomography include those in position emission tomography (PET) and single-photon emission computed tomography (SPECT). Despite its high instrumentation costs, PET is unique among other modalities in its ability for metabolic and physiological imaging. After more than two decades of intensive instrumentation development and application, PET is entering a new era with an increased number of commercial systems and hospital-based cyclotrons being installed in clinical departments. Future research is directed towards high resolution PET imaging systems, pharmaceutical development and exploration of new areas of clinical applications. Due to lower instrumentation costs, SPECT systems are much more widely available than PET. On the other hand, SPECT's limitations include lower sensitivity, difficulties in attenuation and scatter compensation, and availability of truly metabolic and physiological agents. However, in the last few years we have witnessed tremendous advances made in SPECT imaging. In particular, SPECT systems with multiple detectors are now commercially available, offering much better sensitivity and spatial resolution compared to older generation systems and the potential of simultaneous transmission-emission computed tomography. Image processing and reconstruction methods are being developed to provide better image quality and quantitative accuracy. New SPECT radiopharmaceuticals for metabolic and physiological studies are under investigation. These advances will provide an alternative to metabolic and physiological imaging at much lower costs. The paper highlights recent advances in both PET and SPECT and their effects on the future of medical imaging.

AB - Recent advances in emission computed tomography include those in position emission tomography (PET) and single-photon emission computed tomography (SPECT). Despite its high instrumentation costs, PET is unique among other modalities in its ability for metabolic and physiological imaging. After more than two decades of intensive instrumentation development and application, PET is entering a new era with an increased number of commercial systems and hospital-based cyclotrons being installed in clinical departments. Future research is directed towards high resolution PET imaging systems, pharmaceutical development and exploration of new areas of clinical applications. Due to lower instrumentation costs, SPECT systems are much more widely available than PET. On the other hand, SPECT's limitations include lower sensitivity, difficulties in attenuation and scatter compensation, and availability of truly metabolic and physiological agents. However, in the last few years we have witnessed tremendous advances made in SPECT imaging. In particular, SPECT systems with multiple detectors are now commercially available, offering much better sensitivity and spatial resolution compared to older generation systems and the potential of simultaneous transmission-emission computed tomography. Image processing and reconstruction methods are being developed to provide better image quality and quantitative accuracy. New SPECT radiopharmaceuticals for metabolic and physiological studies are under investigation. These advances will provide an alternative to metabolic and physiological imaging at much lower costs. The paper highlights recent advances in both PET and SPECT and their effects on the future of medical imaging.

UR - http://www.scopus.com/inward/record.url?scp=0026391384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026391384&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026391384

VL - 19

SP - 608

EP - 609

JO - Annals of Biomedical Engineering

JF - Annals of Biomedical Engineering

SN - 0090-6964

IS - 5

ER -